Melatonin Alissa Healthcare Research

Melatonin, the active ingredient in Melatonin Alissa Healthcare Research, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to help regulate the sleep‑wake cycle in adults experiencing insomnia, jet lag, or other circadian rhythm disturbances.

GNH USA supplies Melatonin Alissa Healthcare Research as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the melatonin receptor pathway to support normal sleep regulation. It is clinically employed for several sleep‑related conditions: - Insomnia: helps reduce sleep onset latency and improve total sleep time. - Jet lag: assists in realigning the circadian rhythm after rapid time‑zone travel. - Sleep‑wake rhythm disorders: supports the stabilization of abnormal sleep patterns such as delayed sleep phase syndrome.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Daytime sleepiness: occasional residual drowsiness. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Severe skin eruption: Stevens‑Johnson‑type rash. - Mood changes: depression or irritability. - Hallucinations: visual or auditory disturbances. - Seizures: rare occurrence in susceptible individuals.

Before initiating melatonin therapy, consider the following safety measures: - Assess sleep patterns: confirm that the sleep disturbance is appropriate for melatonin use. - Avoid alcohol: concurrent consumption may increase sedation. - Hepatic impairment: use with caution in patients with liver disease. - Mood monitoring: watch for signs of depression or agitation. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Melatonin may interact with other medicines that affect the central nervous system or hemostasis.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - CNS depressants (e.g., benzodiazepines, barbiturates): additive sedative effect.

Moderate Interactions (Monitor Closely):\n- Oral contraceptives: possible reduction in contraceptive efficacy. - Antihypertensives: may enhance blood‑pressure‑lowering effect. - Antiplatelet agents (e.g., aspirin, clopidogrel): monitor for increased bleeding. - SSRIs (e.g., fluoxetine, sertraline): potential for heightened serotonergic activity. - Immunosuppressants (e.g., cyclosporine): monitor drug levels.